SCHEMBL26404753

SCHEMBL26404753

Cc1cc(-c2cc(-c3ccccc3)ccc2Nc2ccc(-c3ccccc3)cc2)cc(N(c2ccc3c(c2)C(C)(C)CCC3(C)C)c2ccc3c(c2)C(C)(C)CCC3(C)C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 12/20 0.37
▸ RARG P13631 12/20 0.37
▸ RARA P10276 11/20 0.37
▸ RXRA P19793 7/20 0.37
▸ RXRB P28702 4/20 0.33
▸ RXRG P48443 4/20 0.33
▸ PGR P06401 2/20 0.31
▸ JAK2 O60674 1/20 0.31
▸ JAK3 P52333 1/20 0.31
▸ PTGER4 P35408 1/20 0.31
▸ MEN1 O00255 2/20 0.30
▸ CYP26A1 O43174 2/20 0.30
▸ CYP3A4 P08684 2/20 0.30
▸ KMT2A Q03164 2/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24561569 0.81 RARB (0.39) RARBRARGRARARXRARXRB
SCHEMBL23445015 0.80 RXRA (0.33) RARBRARGRXRARXRBRXRG
SCHEMBL23447257 0.78 RXRA (0.34) RARBRARGRARARXRARXRB
SCHEMBL23445662 0.77 RXRA (0.32) RARBRARGRXRARXRBRXRG
SCHEMBL23445146 0.76 RXRA (0.33) RARBRARGRXRARXRBRXRG
SCHEMBL29331100 0.76 RARB (0.53) RARBRARGRARARXRARXRB
SCHEMBL29331105 0.76 RARB (0.53) RARBRARGRARARXRARXRB
SCHEMBL29331102 0.76 RARB (0.53) RARBRARGRARARXRARXRB
SCHEMBL26304247 0.76 RARB (0.53) RARBRARGRARARXRARXRB
SCHEMBL26303987 0.76 RARB (0.53) RARBRARGRARARXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320214-A1 ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND LG CHEM, LTD. (KR) 2023-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320214-A1 ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND CYP1A1, AOX1, CYP1B1 RARB 371/4885RARG 356/4885RARA 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback